Spots Global Cancer Trial Database for Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Official Title: Phase IIIb, Multinational, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Certolizumab Pegol, a Pegylated Fab' Fragment of a Humanized Anti-Tumor Necrosis Factor(TNF)-Alpha Monoclonal Antibody, Administered in Subjects With Moderately to Severely Active Crohn's Disease.
Study ID: NCT00552058
Conditions
Study Description
Brief Summary: The primary objective of the study is to evaluate efficacy of certolizumab pegol in inducing clinical remission in patients with moderate to severe Crohn's disease as compared with placebo based on Crohn's Disease Activity Index (CDAI) score at Week 6.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Pell City, Alabama, United States
, Colorado Springs, Colorado, United States
, Lakewood, Colorado, United States
, Littleton, Colorado, United States
, Hollywood, Florida, United States
, Jacksonville, Florida, United States
, New Port Richey, Florida, United States
, Winter Park, Florida, United States
, Chicago, Illinois, United States
, Louisville, Kentucky, United States
, Metairie, Louisiana, United States
, Monroe, Louisiana, United States
, Annapolis, Maryland, United States
, Towson, Maryland, United States
, Chesterfield, Michigan, United States
, West Bloomfield, Michigan, United States
, Rochester, Minnesota, United States
, Raleigh, North Carolina, United States
, Cincinnati, Ohio, United States
, Cleveland, Ohio, United States
, Lancaster, Pennsylvania, United States
, Germantown, Tennessee, United States
, Norfolk, Virginia, United States
, Seattle, Washington, United States
, Concord, New South Wales, Australia
, Box Hill, Victoria, Australia
, Footscray, Victoria, Australia
, Parkville, Victoria, Australia
, Adelaide, , Australia
, Bankstown, , Australia
, Clayton, , Australia
, Fitzroy, , Australia
, Fremantle, , Australia
, Garran, , Australia
, Wien, , Austria
, Bonheiden, , Belgium
, Brussels, , Belgium
, Gent, , Belgium
, Leuven, , Belgium
, Liege, , Belgium
, Roeselare, , Belgium
, Belo-Horizonte, MG, Brazil
, Curitiba, , Brazil
, Goiania, , Brazil
, Porto Alegre, , Brazil
, Rio de Janeiro, , Brazil
, Santo-Andre, , Brazil
, Santos, , Brazil
, Sao Paulo, , Brazil
, Edmonton, Alberta, Canada
, Kelowna, British Columbia, Canada
, Winnipeg, Manitoba, Canada
, Hamilton, Ontario, Canada
, Kingston, Ontario, Canada
, London, Ontario, Canada
, Toronto, Ontario, Canada
, Calgary, , Canada
, Santiago, , Chile
, Vina del Mar, , Chile
, Hradec Kralove, , Czechia
, Hradek Kralove, , Czechia
, Praha 7, , Czechia
, Usti Nad Orlici, , Czechia
, Zlin, , Czechia
, Tallin, , Estonia
, Tartu, , Estonia
, Mikkeli, , Finland
, Berlin, , Germany
, Frankfurt, , Germany
, Freiburg, , Germany
, Homburg, , Germany
, Jena, , Germany
, Kiel, , Germany
, Munchen, , Germany
, Ulm, , Germany
, Wilhelmshaven, , Germany
, Budapest, , Hungary
, Gyor, , Hungary
, Nagykanizsa, , Hungary
, Szeged, , Hungary
, Szombathely, , Hungary
, Beer Sheva, , Israel
, Haifa, , Israel
, Holon, , Israel
, Jerusalem, , Israel
, Kfar Saba, , Israel
, Petha Tikva, , Israel
, Rehovot, , Israel
, Tel Aviv, , Israel
, Zerifin, , Israel
, Bologna, , Italy
, Padova, , Italy
, Roma, , Italy
, Riga, , Latvia
, Valmiera, , Latvia
, Milford, Auckland, New Zealand
, Newton, Wellington, New Zealand
, Auckland, , New Zealand
, Christchurch, , New Zealand
, Hamilton, , New Zealand
, Czestochowa, , Poland
, Lodz, , Poland
, Warszawa, , Poland
, Wroclaw, , Poland
, Bucharest, , Romania
, Cluj Napoca, , Romania
, Constanta, , Romania
, Kazan, , Russian Federation
, Moscow, , Russian Federation
, St. Petersburg, , Russian Federation
, Dniepropetrovsk, , Ukraine
, Donetsk, , Ukraine
, Kiev, , Ukraine
, Kyiv, , Ukraine
, Lviv, , Ukraine
, Simferopol, , Ukraine
Contact Details
Name: UCB Clinical Trial Call Center
Affiliation: +1 877 822 9493 (UCB)
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
